<DOC>
	<DOCNO>NCT00829608</DOCNO>
	<brief_summary>The purpose study determine administration HPV quadrivalent vaccine patient diagnose RRP therapeutic effect clinical course . More specifically , administration vaccine decrease size number papilloma , severity disease ( i.e . hoarseness , inspiratory vs. biphasic stridor , airway obstruction ) use LCAS time interval require surgical debulking analyze .</brief_summary>
	<brief_title>Therapeutic Treatment With Human Papillomavirus Quadrivalent Vaccine Recurrent Respiratory Papillomatosis</brief_title>
	<detailed_description>Patients carry diagnosis Recurrent Respiratory Papillomatosis ( RRP ) ask participate study . These patient follow faculty investigator several year . Their disease state require frequent intervention aim decrease severity symptomatology vocal fold papilloma . Patients give human papillomavirus quadrivalent vaccine clinical course follow next 6 month . Patients laryngoscopic examination prior treatment establish baseline disease state . They repeat laryngoscopic examination time first , second third vaccine injection , give 1 month interval total 3 dos . They physical exam laryngoscopic examination 1 month interval first 6 month administration vaccine . The severity clinical disease objectively measure use validate scale RRP assessment , Laryngoscopic Clinical Assessment Scale ( LCAS ) .</detailed_description>
	<mesh_term>Papilloma</mesh_term>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<mesh_term>Papillomavirus Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>There 9 participant currently follow faculty sponsor 's clinic carry clinical histologic diagnosis RRP . The 9 participant meet one follow criterion : Surgery requirement 4 procedure per year , distal multisite spread disease , rapid regrowth papilloma disease airway compromise . If 9 patient meet follow criterion exclude study : Pregnancy Hypersensitivity allergy vaccine component ( i.e . Saccharomyces cerevisiae yeast ) Immunocompromised patient ( i.e . patient HIV , cancer , take immunosuppressant medication include form steroid ) Have fever 100°F ( 37.8°C ) Moderate severe acute illness ( without fever ) Coagulopathies Platelet count less 100,000 Any history recent treatment ( within 3 month ) investigational drug adjuvant RRP therapy ( include interferongamma , ribavirin , acyclovir , cidofovir photodynamic therapy , indole3carbinol )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>RRP</keyword>
	<keyword>Recurrent Respiratory Papillomatosis</keyword>
	<keyword>HPV vaccine</keyword>
	<keyword>HPV</keyword>
</DOC>